Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study

Jose R. Castillo-Mancilla; Andrew N. Phillips; James D. Neaton; Jacqueline Neuhaus; Simon Collins; Sharon Mannheimer; Sarah Pett; Veronique Touzeau-Römer; Mark N. Polizzotto; Jens D. Lundgren; Edward M. Gardner

doi:10.1093/ofid/ofx275

Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study

Jose R. Castillo-Mancilla, Andrew N. Phillips, James D. Neaton, Jacqueline Neuhaus, Simon Collins, Sharon Mannheimer, Sarah Pett, Veronique Touzeau-Römer, Mark N. Polizzotto, Jens D. Lundgren, Edward M. Gardner

Biostatistics

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Suboptimal (ie, <100%) antiretroviral therapy (ART) adherence has been associated with heightened inflammation in cohort studies, even among people with virologic suppression. We aimed to evaluate this association among participants in the Strategies for Management of Antiretroviral Therapy (SMART) study who had virologic suppression (HIV-1 VL < 200 copies/mL) at enrollment. Based on self-reported adherence (7-day recall), plasma concentrations of interleukin 6 and D-dimer were 9% (95% confidence interval [CI], 1%-18%; P = .02) and 11% (95% CI, 1%-22%; P = .03) higher in participants who reported suboptimal vs 100% adherence, respectively. These findings confirm previous observations and support the hypothesis that suboptimal ART adherence, even in the context of virologic suppression, may have significant biological consequences. ClinicalTrials.gov number NCT00027352.

Original language	English (US)
Article number	ofx275
Journal	Open Forum Infectious Diseases
Volume	5
Issue number	1
DOIs	https://doi.org/10.1093/ofid/ofx275
State	Published - Jan 1 2018

Bibliographical note

Funding Information:
Financial support. This work was supported by National Institute of Health grants: U01AI068641, U01AI042170 and U01AI46362 (SMART) and K23AI104315 (JCM) and R21AI124859 (JCM).

Publisher Copyright:
© 2017 The Author(s).

Keywords

Adherence
SMART study.
antiretroviral therapy
inflammation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1093/ofid/ofx275

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772402

OpenUrl availability

Full text

Cite this

Castillo-Mancilla, J. R., Phillips, A. N., Neaton, J. D., Neuhaus, J., Collins, S., Mannheimer, S., Pett, S., Touzeau-Römer, V., Polizzotto, M. N., Lundgren, J. D., & Gardner, E. M. (2018). Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study. Open Forum Infectious Diseases, 5(1), Article ofx275. https://doi.org/10.1093/ofid/ofx275

Castillo-Mancilla, JR, Phillips, AN, Neaton, JD, Neuhaus, J, Collins, S, Mannheimer, S, Pett, S, Touzeau-Römer, V, Polizzotto, MN, Lundgren, JD & Gardner, EM 2018, 'Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study', Open Forum Infectious Diseases, vol. 5, no. 1, ofx275. https://doi.org/10.1093/ofid/ofx275

@article{638341fb8f92446cb691b03f3326a9e6,

title = "Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study",

abstract = "Suboptimal (ie, <100%) antiretroviral therapy (ART) adherence has been associated with heightened inflammation in cohort studies, even among people with virologic suppression. We aimed to evaluate this association among participants in the Strategies for Management of Antiretroviral Therapy (SMART) study who had virologic suppression (HIV-1 VL < 200 copies/mL) at enrollment. Based on self-reported adherence (7-day recall), plasma concentrations of interleukin 6 and D-dimer were 9% (95% confidence interval [CI], 1%-18%; P = .02) and 11% (95% CI, 1%-22%; P = .03) higher in participants who reported suboptimal vs 100% adherence, respectively. These findings confirm previous observations and support the hypothesis that suboptimal ART adherence, even in the context of virologic suppression, may have significant biological consequences. ClinicalTrials.gov number NCT00027352.",

keywords = "Adherence, SMART study., antiretroviral therapy, inflammation",

author = "Castillo-Mancilla, {Jose R.} and Phillips, {Andrew N.} and Neaton, {James D.} and Jacqueline Neuhaus and Simon Collins and Sharon Mannheimer and Sarah Pett and Veronique Touzeau-R{\"o}mer and Polizzotto, {Mark N.} and Lundgren, {Jens D.} and Gardner, {Edward M.}",

note = "Funding Information: Financial support. This work was supported by National Institute of Health grants: U01AI068641, U01AI042170 and U01AI46362 (SMART) and K23AI104315 (JCM) and R21AI124859 (JCM). Publisher Copyright: {\textcopyright} 2017 The Author(s).",

year = "2018",

month = jan,

day = "1",

doi = "10.1093/ofid/ofx275",

language = "English (US)",

volume = "5",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study

AU - Castillo-Mancilla, Jose R.

AU - Phillips, Andrew N.

AU - Neaton, James D.

AU - Neuhaus, Jacqueline

AU - Collins, Simon

AU - Mannheimer, Sharon

AU - Pett, Sarah

AU - Touzeau-Römer, Veronique

AU - Polizzotto, Mark N.

AU - Lundgren, Jens D.

AU - Gardner, Edward M.

N1 - Funding Information: Financial support. This work was supported by National Institute of Health grants: U01AI068641, U01AI042170 and U01AI46362 (SMART) and K23AI104315 (JCM) and R21AI124859 (JCM). Publisher Copyright: © 2017 The Author(s).

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Suboptimal (ie, <100%) antiretroviral therapy (ART) adherence has been associated with heightened inflammation in cohort studies, even among people with virologic suppression. We aimed to evaluate this association among participants in the Strategies for Management of Antiretroviral Therapy (SMART) study who had virologic suppression (HIV-1 VL < 200 copies/mL) at enrollment. Based on self-reported adherence (7-day recall), plasma concentrations of interleukin 6 and D-dimer were 9% (95% confidence interval [CI], 1%-18%; P = .02) and 11% (95% CI, 1%-22%; P = .03) higher in participants who reported suboptimal vs 100% adherence, respectively. These findings confirm previous observations and support the hypothesis that suboptimal ART adherence, even in the context of virologic suppression, may have significant biological consequences. ClinicalTrials.gov number NCT00027352.

AB - Suboptimal (ie, <100%) antiretroviral therapy (ART) adherence has been associated with heightened inflammation in cohort studies, even among people with virologic suppression. We aimed to evaluate this association among participants in the Strategies for Management of Antiretroviral Therapy (SMART) study who had virologic suppression (HIV-1 VL < 200 copies/mL) at enrollment. Based on self-reported adherence (7-day recall), plasma concentrations of interleukin 6 and D-dimer were 9% (95% confidence interval [CI], 1%-18%; P = .02) and 11% (95% CI, 1%-22%; P = .03) higher in participants who reported suboptimal vs 100% adherence, respectively. These findings confirm previous observations and support the hypothesis that suboptimal ART adherence, even in the context of virologic suppression, may have significant biological consequences. ClinicalTrials.gov number NCT00027352.

KW - Adherence

KW - SMART study.

KW - antiretroviral therapy

KW - inflammation

UR - http://www.scopus.com/inward/record.url?scp=85044642159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044642159&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofx275

DO - 10.1093/ofid/ofx275

M3 - Article

C2 - 29362724

AN - SCOPUS:85044642159

SN - 2328-8957

VL - 5

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - 1

M1 - ofx275

ER -

Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this